|
Synthesizing and investigating novel synthetic cannabidiol congeners for enhanced clinical utility
Title:
Synthetic Cannabidiol Congeners for Enhanced Clinical Utility
Tech ID:
2023-001
Status:
Active
Category:
Pharmaceuticals and Synthetic Cannabinoid Research
Executive Statement:
Innovative synthetic cannabidiol compounds designed to improve treatment options for seizures, anxiety, and inflammatory conditions.
Description:
This technology...
Published: 7/15/2026
|
Updated: 3/14/2024
|
Inventor(s): Rochelle Hines, Dustin Hines, William Maio
Keywords(s): Chemistry, Life Science, Life Science - Health, Therapeutics & Drug Delivery, Therapeutics & Drug Delivery - Therapeutic
Category(s): All
|